Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+14.53%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$42.9B
AUM Growth
+$4.48B
(+12%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
2,645
New
116
Increased
1,247
Reduced
635
Closed
120
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$99.9M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$52.2M |
| 3 |
Take-Two Interactive
TTWO
|
+$46M |
| 4 |
Amazon
AMZN
|
+$40.6M |
| 5 |
Synopsys
SNPS
|
+$37.8M |
Top Sells
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$83.6M |
| 2 |
ASML
ASML
|
+$73.7M |
| 3 |
NVIDIA
NVDA
|
+$69.1M |
| 4 |
WisdomTree US LargeCap Dividend Fund
DLN
|
+$64.3M |
| 5 |
Nucor
NUE
|
+$56.8M |
Sector Composition
| 1 | Technology | 29.11% |
| 2 | Industrials | 10.77% |
| 3 | Consumer Discretionary | 8.76% |
| 4 | Energy | 8.29% |
| 5 | Materials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
First American
FAF
$6.93B
| $648K | ﹤0.01% |
11,649
+277
| +2% | +$15.4K |
|
1802
Upbound Group
UPBD
$1.48B
| $648K | ﹤0.01% |
26,432
| – | – |
|
1803
Aurinia Pharmaceuticals
AUPH
$1.68B
| $647K | ﹤0.01% |
59,059
-79
| -0.1% | -$866 |
|
|
EVRI
1804
DELISTED
Everi Holdings
EVRI
| $647K | ﹤0.01% |
37,720
+993
| +3% | +$17K |
|
|
CDMO
1805
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $647K | ﹤0.01% |
34,479
+6,697
| +24% | +$126K |
|
1806
Expro
XPRO
$1.45B
| $645K | ﹤0.01% |
35,114
| – | – |
|
1807
Ultra Clean Holdings
UCTT
$1.16B
| $644K | ﹤0.01% |
19,413
| – | – |
|
|
TGH
1808
DELISTED
Textainer Group Holdings limited
TGH
| $643K | ﹤0.01% |
20,012
| – | – |
|
1809
MGIC Investment
MTG
$6.67B
| $642K | ﹤0.01% |
47,850
| – | – |
|
1810
Abercrombie & Fitch
ANF
$4.44B
| $637K | ﹤0.01% |
22,970
| – | – |
|
|
CD
1811
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $637K | ﹤0.01% |
+91,084
| New | +$637K |
|
1812
Autohome
ATHM
$3.5B
| $637K | ﹤0.01% |
19,018
+5,527
| +41% | +$185K |
|
1813
Protagonist Therapeutics
PTGX
$3.71B
| $635K | ﹤0.01% |
27,629
+7,752
| +39% | +$178K |
|
1814
Sprinklr
CXM
$1.93B
| $634K | ﹤0.01% |
48,901
+372
| +0.8% | +$4.82K |
|
1815
LiveRamp
RAMP
$1.77B
| $634K | ﹤0.01% |
28,895
+728
| +3% | +$16K |
|
1816
Energy Recovery
ERII
$773M
| $627K | ﹤0.01% |
27,187
+1,031
| +4% | +$23.8K |
|
1817
Privia Health
PRVA
$2.81B
| $626K | ﹤0.01% |
22,680
+2,752
| +14% | +$76K |
|
|
PGTI
1818
DELISTED
PGT, Inc.
PGTI
| $622K | ﹤0.01% |
24,789
-414
| -2% | -$10.4K |
|
1819
Arvinas
ARVN
$573M
| $622K | ﹤0.01% |
22,771
-33
| -0.1% | -$902 |
|
1820
Astrana Health
ASTH
$1.4B
| $622K | ﹤0.01% |
17,051
+500
| +3% | +$18.2K |
|
1821
Gildan
GIL
$8.23B
| $618K | ﹤0.01% |
18,636
-2,156
| -10% | -$71.5K |
|
1822
St. Joe Company
JOE
$3.05B
| $617K | ﹤0.01% |
14,831
| – | – |
|
1823
NBT Bancorp
NBTB
$2.29B
| $616K | ﹤0.01% |
18,274
-861
| -4% | -$29K |
|
1824
Zions Bancorporation
ZION
$8.6B
| $615K | ﹤0.01% |
20,555
+1,780
| +9% | +$53.3K |
|
1825
Heidrick & Struggles
HSII
$1.05B
| $613K | ﹤0.01% |
20,193
| – | – |
|